Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis

•This meta-analysis compared the efficacy of ICIs between younger and older patients.•ICIs significantly improved OS in both younger (HR, 0.75) and older (HR, 0.73) groups.•An improvement in PFS was observed in younger (HR, 0.58) and older (HR, 0.77) patients.•In the PD-1 inhibitor subgroup, a signi...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cancer treatment reviews Ročník 45; s. 30 - 37
Hlavní autoři:	Nishijima, Tomohiro F., Muss, Hyman B., Shachar, Shlomit S., Moschos, Stergios J.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier Ltd 01.04.2016
Témata:	Age Age Factors Aging - immunology Antibodies, Monoclonal - classification Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacology Antineoplastic Agents - classification Antineoplastic Agents - immunology Antineoplastic Agents - pharmacology Disease-Free Survival Hematology, Oncology and Palliative Medicine Humans Immune checkpoint inhibitor Immunosenescence Meta-analysis Neoplasms - drug therapy Neoplasms - immunology Overall survival Progression-free survival Randomized Controlled Trials as Topic Systematic review Treatment Outcome Immune checkpoint inhibitor Immunosenescence Systematic review Overall survival Progression-free survival Age Meta-analysis
ISSN:	0305-7372, 1532-1967, 1532-1967
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!